Literature DB >> 2569043

Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies.

B E Johnson1, J Whang-Peng, S L Naylor, B Zbar, H Brauch, E Lee, A Simmons, E Russell, M H Nam, A F Gazdar.   

Abstract

In small cell lung carcinoma, one of the short arms of chromosome 3 is typically lost. To investigate chromosome 3 in extrapulmonary small cell carcinoma, we used DNA probes that detect restriction-fragment-length polymorphisms at loci on 3p. These probes were used to study DNA extracted from tumors and normal tissues and/or tumor cell lines from five patients with extrapulmonary small cell cancer. Tumor DNA from four of the five patients with extrapulmonary small cell cancer retained heterozygosity at loci on 3p. Cytogenetic studies of the tumor cell lines established from these four patients showed retention of both short arms of chromosome 3. We conclude that the loss of genetic material from 3p observed in small cell lung cancer is not typical in extrapulmonary small cell cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569043     DOI: 10.1093/jnci/81.16.1223

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  8 in total

1.  Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.

Authors:  Kirsten D Mertz; Sunita R Setlur; Saravana M Dhanasekaran; Francesca Demichelis; Sven Perner; Scott Tomlins; Joëlle Tchinda; Bharathi Laxman; Robert L Vessella; Rameen Beroukhim; Charles Lee; Arul M Chinnaiyan; Mark A Rubin
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

2.  Patient-specific Boolean models of signalling networks guide personalised treatments.

Authors:  Julio Saez-Rodriguez; Laurence Calzone; Arnau Montagud; Jonas Béal; Luis Tobalina; Pauline Traynard; Vigneshwari Subramanian; Bence Szalai; Róbert Alföldi; László Puskás; Alfonso Valencia; Emmanuel Barillot
Journal:  Elife       Date:  2022-02-15       Impact factor: 8.713

3.  Small cell lung cancer.

Authors:  Gregory P Kalemkerian; Wallace Akerley; Paul Bogner; Hossein Borghaei; Laura Qm Chow; Robert J Downey; Leena Gandhi; Apar Kishor P Ganti; Ramaswamy Govindan; John C Grecula; James Hayman; Rebecca Suk Heist; Leora Horn; Thierry Jahan; Marianna Koczywas; Billy W Loo; Robert E Merritt; Cesar A Moran; Harvey B Niell; Janis O'Malley; Jyoti D Patel; Neal Ready; Charles M Rudin; Charles C Williams; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2013-01-01       Impact factor: 11.908

4.  Effective monotherapy with amrubicin for a refractory extrapulmonary small-cell carcinoma of the liver.

Authors:  Taichi Isobe; Shunichi Yanai; Hitoshi Kusaba; Shinichiro Yada; Yosuke Kuroda; Sadafumi Tamiya; Takayuki Matsumoto; Eishi Baba; Mine Harada
Journal:  Case Rep Med       Date:  2009-06-16

5.  Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer.

Authors:  W Nathaniel Brennen; Yezi Zhu; Ilsa M Coleman; Susan L Dalrymple; Lizamma Antony; Radhika A Patel; Brian Hanratty; Roshan Chikarmane; Alan K Meeker; S Lilly Zheng; Jody E Hooper; Jun Luo; Angelo M De Marzo; Eva Corey; Jianfeng Xu; Srinivasan Yegnasubramanian; Michael C Haffner; Peter S Nelson; William G Nelson; William B Isaacs; John T Isaacs
Journal:  JCI Insight       Date:  2021-04-22

6.  The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins.

Authors:  Andrew D Rouillard; Gregory W Gundersen; Nicolas F Fernandez; Zichen Wang; Caroline D Monteiro; Michael G McDermott; Avi Ma'ayan
Journal:  Database (Oxford)       Date:  2016-07-03       Impact factor: 3.451

7.  Primary Hepatic Small-Cell Carcinoma Developed during Antiviral Treatment for Chronic Hepatitis B.

Authors:  Suk Bae Kim
Journal:  Case Rep Gastroenterol       Date:  2015-12-12

8.  Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4.

Authors:  Yinan Li; Ruiqi Chen; Mary Bowden; Fan Mo; Yen-Yi Lin; Martin Gleave; Colin Collins; Xuesen Dong
Journal:  Oncotarget       Date:  2017-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.